DMCC Speciality Chemicals Ltd

DMCC Speciality Chemicals Limited has responded to a clarification sought by the stock exchange regarding a significant increase in security volume. The company stated that it is in compliance with SEBI (LODR) Regulations, 2015, and has been promptly intimating the exchange of all material events. DMCC Speciality Chemicals confirmed there is no undisclosed price-sensitive information or impending corporate action that could explain the recent volume behavior. The company attributes the movement purely to market-driven factors beyond its control or knowledge.

DMCC Speciality Chemicals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from July 1st, 2026, and will remain in effect until 48 hours after the conclusion of the Board Meeting where the Unaudited Standalone and Consolidated Financial Results for the quarter ending June 30th, 2026, will be considered. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. All designated employees are advised against trading in the company's securities during this period. The exact date of the Board meeting will be communicated separately.

DMCC Speciality Chemicals Ltd received an order regarding an appeal filed by the Department against Order-In-Original no. RGD/DIV-III/AC/MAF/04/2023-24. The appeal contests the dropping of a demand for inadmissible Input Tax Credit (ITC) amounting to ₹1,05,98,933. The department argues that the adjudicating authority incorrectly interpreted Section 17(5) of the CGST Act. DMCC believes the demand is not maintainable and is planning an appeal. The company states that the order has no material impact on its financials or operations.

DMCC Speciality Chemicals Ltd reported its Q4 & FY26 financial performance. Q4FY26 revenue from operations stood at ₹177.64 Cr, up 17.75% Q-o-Q and 41.87% Y-o-Y. EBITDA was ₹17.86 Cr, up 19.81% Q-o-Q and 14.73% Y-o-Y. Profit after tax was ₹7.65 Cr, up 24.08% Q-o-Q and 18.27% Y-o-Y. The company faced raw material availability challenges at its Roha site but managed to pass on increased costs to customers.

DMCC Speciality Chemicals Ltd reported its Q4 FY26 financial performance, with revenue from operations at ₹177.64 Cr, a 41.87% increase Y-o-Y. EBITDA stood at ₹17.86 Cr, up 14.73% Y-o-Y, and profit after tax was ₹7.65 Cr, up 18.27% Y-o-Y. The company faced raw material availability challenges at its Roha site due to Middle East conflict impacting sulphur prices. Despite challenges, DMCC managed to pass on increased costs to customers, protecting profitability. The company is focused on maintaining operational stability and managing working capital.

DMCC Speciality Chemicals Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of 25% (₹2.50 per share) was recommended, subject to shareholder approval. Shri S. S. Dongare was appointed as Cost Auditor for FY27. The 105th AGM will be held on September 11, 2026, via video conferencing.

DMCC Speciality Chemicals Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of 25% (₹2.50 per share) was recommended, subject to shareholder approval. Shri S. S. Dongare was appointed as Cost Auditor for FY27. The 105th AGM will be held on September 11, 2026, via video conferencing.

DMCC Speciality Chemicals Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of 25% (₹2.50 per share) was recommended, subject to shareholder approval. Shri S. S. Dongare was appointed as Cost Auditor for FY27. The 105th AGM will be held on September 11, 2026, via video conferencing. The board meeting concluded on May 15, 2026. The company's operations are limited to manufacturing and sale of chemicals.

DMCC Speciality Chemicals Ltd has scheduled a Board of Directors meeting on May 15, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend for the fiscal year, subject to shareholder approval at the upcoming 105th Annual General Meeting. The trading window for the company's securities will be closed until May 17, 2026, and will reopen on May 18, 2026.

DMCC Speciality Chemicals Ltd responded to a clarification request from the stock exchange regarding a significant increase in its security price. The company stated it is in full compliance with SEBI (LODR) Regulations, 2015, and has consistently informed the exchanges of all material and price-sensitive information. DMCC confirmed that there is no undisclosed price-sensitive information or any impending announcement/corporate action that could explain the recent price and volume behavior in its shares. The company attributed the movement in its share price and volume to purely market-driven factors and prevailing market conditions, over which it has no control or specific knowledge of the reasons. DMCC reiterated its commitment to promptly inform the exchanges of all material events as required by regulations.